We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

このCiplamedについて

エビデンスに基づく実践のリソース&アップデートを提供する医療友愛のためのアプリ

Ciplamed is a uniquely designed, comprehensive online medical portal for healthcare professionals. Ciplamed provides a range of evidence-based and clinically relevant practice resources across 18 medical specialties. These resources include:

1. eCME / Webcasts

Over 200 video lectures by national and international opinion leaders on a variety of topics

2. Slide library

One of its kind resource for academicians to use for their talks and knowledge

3. Product index

Quick and easy access to the product information of our products marketed in India

4. Patient education materials

Simple, concise and easy to understand material, a clinician can use for his patients

5. Medical news

Bring the latest information a clinician can use after scanning through the leading publications in different therapeutic areas

6. Our publications

In-house publications on different topics for quick guide to clinicians

7. Conference Highlights

Keenly summarizing the latest information presented at key conferences across the globe to ensure doctors are abreast of the latest

8. Links to key guidelines

9. Respi connect provides access to 400 plus practice resources in the field of respiratory

An aggregation of management guidelines from leading medical societies from across the globe

This site as a popular go-to resource for the medical professionals. We invite you to explore the new Ciplamed app.

最新バージョン 2.0.1 の更新情報

Last updated on 2020年01月22日

minor bug fixes

翻訳中...

アプリの追加情報

最終のバージョン

Ciplamed 更新を申請する 2.0.1

投稿者

Marky Jimenez

Android 要件

Android 4.2+

もっと見る

Ciplamed スクリーンショット

言語
APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
購読完了!
APKPureの購読が完了しました。
APKPureをを購読する
最高のAndroidゲームアプリの最新リリースやニュースやガイドなどの情報にいち早くアクセスすることができます。
いいえ結構です
購読
成功!
ニュースレターを購読しました。